Anti-Aging Clinics Appeal to Menopausal Women
the Endocrinology Advisor take:
Women have been seeking treatment for their menopausal symptoms from ‘anti-aging’ clinicians, according to a study evaluating the appeal of anti-aging medicine.
Some women believed that conventional doctors did not take their symptoms seriously, the findings suggested, while some also were afraid of side effects of conventional hormone replacement therapy.
However, they considered the bioidentical hormones, or “natural” hormones, prescribed by the anti-aging clinicians to be safe despite a lack of evidence.
The researchers also conducted in-depth interviews with 25 women who used bioidentical hormone replacement therapy prescribed by anti-aging clinicians. Their goals, they reported, were relieving menopausal symptoms, increasing energy and avoiding chronic illnesses.
Other reasons women visited anti-aging clinicians included the belief that patients received more time and attention from clinicians; medications were viewed as “natural”; and bioidentical hormone replacement therapy was seen as safer than conventional hormone therapy.
Women were often prescribed bioidentical hormone therapy derived from plants such as soy and yams. These hormonal therapies are unregulated by the FDA and produced at compounding pharmacies.
Nurse-managed protocols improved outpatient care in chronic illnesses
Endocrinology Advisor Articles
- Two Phases of C-Peptide Decline Identified in Type I Diabetes
- Dulaglutide Effective for Patients With T2D, Moderate to Severe CKD
- Incidence of Diabetes Influenced by Endocrine-Disrupting Chemicals in the Environment
- Guidelines for Management of Hypothalamic-Pituitary, Growth Disorders in Childhood Cancer Survivors
- Romosozumab: Effective in Men With Osteoporosis
- Using Latent Class Trajectory Analysis to Determine Glucose Response Curve Patterns
- First CGM System With Implantable Glucose Sensor Approved
- Adjunctive Metformin for Insulin Resistance in T1D: A Clinical Perspective
- Risk for Below Knee Amputations With Canagliflozin vs Other Antihyperglycemic Agents
- Empagliflozin, Linagliptin Combination Therapy vs Linagliptin Monotherapy for Type 2 Diabetes
- NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
- Placebo Effect of Various Female Sexual Dysfunction Drug Txs Assessed
- Link Between Oral Diabetes Medications and Bullous Pemphigoid
- Calcium Channel Blocker May Benefit Patients With Type 1 Diabetes
- β-Cell Function in Youth With Impaired Glucose Tolerance, T2D